Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Free Patent Expiration Alerts


Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Esomeprazole sodium - Generic Drug Details

« Back to Dashboard
Esomeprazole sodium is the generic ingredient in two branded drugs marketed by Accord Hlthcare, Sun Pharma Global, and Astrazeneca Pharms, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty drug master file entries for esomeprazole sodium. Five suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: esomeprazole sodium

Tradenames:2
Patents:0
Applicants:3
NDAs:3
Drug Master File Entries: see list60
Suppliers / Packaging: see list5
Formulation / Manufacturing:see details

Pharmacology for Ingredient: esomeprazole sodium

Tentative approvals for ESOMEPRAZOLE SODIUM

Applicant Application No. Form Dosage
<disabled><disabled>INJECTABLE;INJECTION40MG

Clinical Trials for: esomeprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS200882-001Mar 18, 2013RXNo<disabled><disabled>
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-002Mar 31, 2005RXYes<disabled><disabled>
Accord Hlthcare
ESOMEPRAZOLE SODIUM
esomeprazole sodium
INJECTABLE;INTRAVENOUS205379-001Sep 25, 2015RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: esomeprazole sodium

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-001Mar 31, 20055,877,192*PED<disabled>
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-001Mar 31, 20056,143,771<disabled>
Astrazeneca Pharms
NEXIUM IV
esomeprazole sodium
INJECTABLE;INTRAVENOUS021689-002Mar 31, 20055,877,192*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc